Incyte director Edmund Harrigan acquires 206 shares
A director received fully vested restricted shares in lieu of quarterly director retainer fees.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Incyte Corp. director Edmund Harrigan acquired 206 fully vested restricted shares on September 30, 2026. They were issued under the company’s Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees, following an election intended to comply with Rule 10b5-1. The reported per-share amount was $121.35.
Harrigan reported 23,225 shares following the transaction; that amount includes 1,642 shares issuable under previously reported restricted stock units that have not vested.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1, F2 | 206 | $121.35 | $25K |
Footnotes (2)
- F1. Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1. Restricted shares are fully vested.
- F2. This includes an aggregate of 1,642 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
Key Figures
Key Terms
Rule 10b5-1 regulatory
restricted stock units financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.